Natrijev Klorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natrijev Klorid Fresenius Kabi, is an electrolyte solution presented as an injection solution for intravenous use. It provides sodium and chloride ions to restore extracellular fluid volume and electrolyte balance in patients who need fluid replacement, such as those with dehydration, hyponatremia, or postoperative fluid loss.

GNH USA supplies Natrijev Klorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with the product manufactured under EU quality standards.

Natrijev Klorid Fresenius Kabi, an intravenous electrolyte solution, is used to manage conditions that require restoration of fluid and electrolyte balance. - Fluid replacement: Replenishes intravascular volume in patients with acute fluid loss. - Hyponatremia: Increases serum sodium concentration to correct low sodium levels. - Dehydration: Supplies necessary sodium and chloride to rehydrate patients. - Post‑operative care: Maintains adequate circulating volume after surgery.

Intravenous administration of Sodium Chloride may be associated with the following adverse reactions.

Common Side Effects: - Phlebitis at infusion site: mild inflammation or pain. - Hypernatremia: elevated serum sodium when given in large volumes. - Fluid overload: peripheral edema or increased blood pressure.

Serious or Rare Side Effects: - Severe hypernatremia: neurological disturbances such as confusion or seizures. - Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm, or hypotension. - Pulmonary edema: rapid volume expansion leading to respiratory distress.

When using Natrijev Klorid Fresenius Kabi, several precautions should be observed to ensure safe administration. - Assess volume status: evaluate patient’s fluid balance before administration. - Monitor electrolytes: check serum sodium and chloride levels during therapy. - Adjust infusion rate: avoid rapid large‑volume infusion in patients at risk of heart failure. - Avoid in patients with severe hypernatremia: may worsen the condition. - Use aseptic technique: ensure sterility of IV line and solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Sodium Chloride injection can interact with other agents that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use can cause severe hypernatremia. - Loop diuretics (e.g., furosemide): may lead to rapid shifts in sodium and fluid status.

Moderate Interactions (Monitor Closely): - Potassium chloride or potassium‑sparing agents: monitor serum potassium levels. - Corticosteroids: may enhance fluid retention, requiring volume assessment. - Blood products (e.g., packed red cells): may alter overall electrolyte composition.